Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Sava

Showing results (181-190 of 194) with videos related to

Pageof 20
Sort By:
International Journal of Cancer|September 27, 1996
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complexG Sava, I Capozzi, A Bergamo, et al.
Journal of Experimental Therapeutics & Oncology|November 1, 1996
Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinomaG Sava, A Bergamo, I Capozzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patientsG Cartei, G Sava, G Salerno, et al.
Frontiers in Immunology|July 9, 2019
Complex Bacterial Consortia Reprogram the Colitogenic Activity of <i>Enterococcus faecalis</i> in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated ColitisIsabella Lengfelder, Irina G Sava, Jonathan J Hansen, et al.
Fresenius' Journal of Analytical Chemistry|March 29, 2001
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometryM Crul, H J van den Bongard, M M Tibben, et al.
The Journal of Biological Chemistry|April 28, 2009
Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cellsIrina G Sava, Fuming Zhang, Ioana Toma, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Biochemical and biological characteristics of leucocyte proteinase inhibitorsM Kopitar, M Drobnic-Kosorok, J Babnik, et al.
Plos One|August 25, 2015
Correction: Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune ResponseChristian Theilacker, Ann-Kristin Diederich, Andreas Otto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-AG Sava, A Bergamo, S Zorzet, et al.
Plos One|July 15, 2015
Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune ResponseChristian Theilacker, Ann-Kristin Diederich, Andreas Otto, et al.
Pageof 20

Showing results (181-190 of 194) with videos related to

Sort By:
Pageof 20
International Journal of Cancer|September 27, 1996
Down-regulation of tumour gelatinase/inhibitor balance and preservation of tumour endothelium by an anti-metastatic ruthenium complexG Sava, I Capozzi, A Bergamo, et al.
Journal of Experimental Therapeutics & Oncology|November 1, 1996
Stimulation of GALT and activation of mesenteric lymph node lymphocytes by a modified lysozyme in CBA mice with MCa mammary carcinomaG Sava, A Bergamo, I Capozzi, et al.
Cancer Biotherapy & Radiopharmaceuticals|April 1, 1996
Synthetic thymic fraction 5: effects of high dose administration on circulating lymphocytes in patientsG Cartei, G Sava, G Salerno, et al.
Frontiers in Immunology|July 9, 2019
Complex Bacterial Consortia Reprogram the Colitogenic Activity of <i>Enterococcus faecalis</i> in a Gnotobiotic Mouse Model of Chronic, Immune-Mediated ColitisIsabella Lengfelder, Irina G Sava, Jonathan J Hansen, et al.
Fresenius' Journal of Analytical Chemistry|March 29, 2001
Validated method for the determination of the novel organo-ruthenium anticancer drug NAMI-A in human biological fluids by Zeeman atomic absorption spectrometryM Crul, H J van den Bongard, M M Tibben, et al.
The Journal of Biological Chemistry|April 28, 2009
Novel interactions of glycosaminoglycans and bacterial glycolipids mediate binding of enterococci to human cellsIrina G Sava, Fuming Zhang, Ioana Toma, et al.
Advances in Experimental Medicine and Biology|January 1, 1982
Biochemical and biological characteristics of leucocyte proteinase inhibitorsM Kopitar, M Drobnic-Kosorok, J Babnik, et al.
Plos One|August 25, 2015
Correction: Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune ResponseChristian Theilacker, Ann-Kristin Diederich, Andreas Otto, et al.
European Journal of Cancer (Oxford, England : 1990)|January 31, 2002
Influence of chemical stability on the activity of the antimetastasis ruthenium compound NAMI-AG Sava, A Bergamo, S Zorzet, et al.
Plos One|July 15, 2015
Enterococcus faecalis Glycolipids Modulate Lipoprotein-Content of the Bacterial Cell Membrane and Host Immune ResponseChristian Theilacker, Ann-Kristin Diederich, Andreas Otto, et al.
Pageof 20